世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の脳症治療市場 2019-2023年

Global Encephalopathy Treatment Market 2019-2023

IRTNTR30076

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年10月US$2,500
シングルユーザライセンス
104

サマリー

この調査レポートは世界の脳症治療市場を分析・予測したTechNavioの市場調査報告書です。

Description

About Encephalopathy
Encephalopathy is a disease that affects the functioning and structure of the brain. It can be temporary, permanent, or neonatal.
Technavio’s analysts forecast the Global Encephalopathy Treatment Market to grow at a CAGR of 4.75% during the period 2019-2023.

Covered in this report
The report covers the present scenario and the growth prospects of the encephalopathy treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of encephalopathy across the globe.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, encephalopathy treatment market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendor
- Bausch Health
Market driver
- Rise in initiatives to increase the awareness about encephalopathy disease management
- For a full, detailed list, view our report

Market challenge
- Adverse effects associated with available drugs
- For a full, detailed list, view our report

Market trend
- Emergence of novel treatment targets for encephalopathy
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2023 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
- Pipeline Analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Hepatic encephalopathy - Market size and forecast 2018-2023
- Diabetic encephalopathy - Market size and forecast 2018-2023
- Infectious encephalopathy - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Emergence of novel treatment targets for encephalopathy
- Increase in FDA drug approval for diseases associated with encephalopathy
- Increase in adoption of technological advances for treating encephalopathy
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Market positioning of vendors
- Bausch Health
PART 15: APPENDIX
- Research methodology
- List of abbreviations
PART 16: EXPLORE TECHNAVIO

?
Exhibit 01: Global CNS disorder drugs market
Exhibit 02: Segments of global cns disorder drugs market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pipeline drugs under phase I/II development
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Type - Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Hepatic encephalopathy - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Hepatic encephalopathy - Year-over-year growth 2019-2023 (%)
Exhibit 22: Diabetic encephalopathy - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Diabetic encephalopathy - Year-over-year growth 2019-2023 (%)
Exhibit 24: Infectious encephalopathy - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Infectious encephalopathy - Year-over-year growth 2019-2023 (%)
Exhibit 26: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Others - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by type
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Bausch Health - Vendor overview
Exhibit 50: Bausch Health - Business segments
Exhibit 51: Bausch Health - Organizational developments
Exhibit 52: Bausch Health - Geographic focus
Exhibit 53: Bausch Health - Segment focus
Exhibit 54: Bausch Health - Key offerings

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る